相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
Ali Mirzazadeh et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2022)
Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
Masashi Mizokami et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program
Fergus Stafford et al.
MEDICAL JOURNAL OF AUSTRALIA (2021)
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
Shahin Merat et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cost-effectiveness of pan-genotypic direct-acting antiviral regimens for treatment of chronic Hepatitis C in the United States
Stuart Gordon et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
Alessandra Mangia et al.
LIVER INTERNATIONAL (2020)
Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia
Josephine G. Walker et al.
LIVER INTERNATIONAL (2020)
Cost-utility of sofosbuvir/velpatasvir versus other direct-acting antivirals for chronic hepatitis C genotype 1b infection in China
Haoya Yun et al.
BMJ OPEN (2020)
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
Melissa J. Barber et al.
JOURNAL OF VIRUS ERADICATION (2020)
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic
Sahar Bajis et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
On time horizons in health economic evaluations
Markus Haacker et al.
HEALTH POLICY AND PLANNING (2020)
Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective
Xia Wei et al.
BMJ GLOBAL HEALTH (2020)
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Sanam Hariri et al.
HARM REDUCTION JOURNAL (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study
Beth Catlett et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Real-world cost-effectiveness of pangenotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India
Yashika Chugh et al.
PLOS ONE (2019)
Willingness to pay for one quality-adjusted life year in Iran
Najmeh Moradi et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2019)
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
Maryam Alavi et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective
Helena H. L. Borba et al.
VALUE IN HEALTH REGIONAL ISSUES (2019)
Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
Joseph K. Lim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment
Amit Goel et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection
Heidar Sharafi et al.
HEPATITIS MONTHLY (2017)
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Seyed Moayed Alavian et al.
HEPATITIS MONTHLY (2017)
Generic Direct Acting Antiviral Treatment: The First Step Towards Elimination of Hepatitis C in Iran
Behzad Hajarizadeh
HEPATITIS MONTHLY (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection A Systematic Review and Meta-analysis
J. Morgan Freiman et al.
ANNALS OF INTERNAL MEDICINE (2016)
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
Vito Di Marco et al.
GASTROENTEROLOGY (2016)
Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
Behzad Hajarizadeh et al.
HEPATITIS MONTHLY (2016)
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis
Hossein Ghaderi-Zefrehi et al.
HEPATITIS MONTHLY (2016)
A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
Seyed Moayed Alavian et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2016)
Hepatitis C treatment as prevention: evidence, feasibility, and challenges
Behzad Hajarizadeh et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
Jagpreet Chhatwal et al.
ANNALS OF INTERNAL MEDICINE (2015)
A path to eradication of hepatitis C in low- and middle-income countries
Camilla S. Graham et al.
ANTIVIRAL RESEARCH (2015)
Hepatitis C Virus Therapeutic Development: In Pursuit of Perfectovir
Gregory J. Dore et al.
CLINICAL INFECTIOUS DISEASES (2015)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naive Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis
Thanthima Suwanthawornkul et al.
PLOS ONE (2015)
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
S. Saab et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Chronic hepatitis C virus (HCV) disease burden and cost in the United States
Homie Razavi et al.
HEPATOLOGY (2013)
Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein
Jianping Liu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
Roberta D'Ambrosio et al.
HEPATOLOGY (2012)
A Prospective Study of the Rate of Progression in Compensated, Histologically Advanced Chronic Hepatitis C
Jules L. Dienstag et al.
HEPATOLOGY (2011)
Timing of Hepatitis C Antiviral Therapy in Patients with Advanced Liver Disease: A Decision Analysis Model
Sammy Saab et al.
LIVER TRANSPLANTATION (2010)
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C
Sarah Maylin et al.
GASTROENTEROLOGY (2008)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Treating viral hepatitis C: Efficacy, side effects, and complications
M. P. Manns et al.
GUT (2006)
分享论文
